These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 37958483)

  • 1. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities.
    Bogut A; Stojanovic B; Jovanovic M; Dimitrijevic Stojanovic M; Gajovic N; Stojanovic BS; Balovic G; Jovanovic M; Lazovic A; Mirovic M; Jurisevic M; Jovanovic I; Mladenovic V
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3's Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential.
    Dimitrijevic Stojanovic M; Stojanovic B; Radosavljevic I; Kovacevic V; Jovanovic I; Stojanovic BS; Prodanovic N; Stankovic V; Jocic M; Jovanovic M
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.
    Martínez-Bosch N; Fernández-Barrena MG; Moreno M; Ortiz-Zapater E; Munné-Collado J; Iglesias M; André S; Gabius HJ; Hwang RF; Poirier F; Navas C; Guerra C; Fernández-Zapico ME; Navarro P
    Cancer Res; 2014 Jul; 74(13):3512-24. PubMed ID: 24812270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC.
    Abudu O; Nguyen D; Millward I; Manning JE; Wahid M; Lightfoot A; Marcon F; Merard R; Margielewska-Davies S; Roberts K; Brown R; Powell-Brett S; Nicol SM; Zayou F; Croft WD; Pearce H; Moss P; Iqbal AJ; McGettrick HM
    Biomed Pharmacother; 2024 Mar; 172():116283. PubMed ID: 38377735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma.
    Xue X; Lu Z; Tang D; Yao J; An Y; Wu J; Li Q; Gao W; Xu Z; Qian Z; Dai C; Wei J; Miao Y; Jiang K
    Pancreas; 2011 Aug; 40(6):832-9. PubMed ID: 21747316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma.
    Chen R; Pan S; Ottenhof NA; de Wilde RF; Wolfgang CL; Lane Z; Post J; Bronner MP; Willmann JK; Maitra A; Brentnall TA
    Cancer Biol Ther; 2012 Aug; 13(10):899-907. PubMed ID: 22785208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment.
    Tarannum M; Vivero-Escoto JL
    Adv Drug Deliv Rev; 2022 Aug; 187():114357. PubMed ID: 35605679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.
    Tang D; Zhang J; Yuan Z; Gao J; Wang S; Ye N; Li P; Gao S; Miao Y; Wang D; Jiang K
    PLoS One; 2014; 9(3):e90476. PubMed ID: 24595374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
    Kabacaoglu D; Ciecielski KJ; Ruess DA; Algül H
    Front Immunol; 2018; 9():1878. PubMed ID: 30158932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
    Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
    Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
    Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
    Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 15. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions.
    Bandi DSR; Sarvesh S; Farran B; Nagaraju GP; El-Rayes BF
    Cytokine Growth Factor Rev; 2023; 71-72():26-39. PubMed ID: 37407355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Galectin 4 Drives Immune Evasion and Promotes T-cell Apoptosis in Pancreatic Cancer.
    Lidström T; Cumming J; Gaur R; Frängsmyr L; Pateras IS; Mickert MJ; Franklin O; Forsell MNE; Arnberg N; Dongre M; Patthey C; Öhlund D
    Cancer Immunol Res; 2023 Jan; 11(1):72-92. PubMed ID: 36478037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma.
    Maftouh M; Belo AI; Avan A; Funel N; Peters GJ; Giovannetti E; Van Die I
    Oncotarget; 2014 Jul; 5(14):5335-49. PubMed ID: 24977327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.
    Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P
    Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.
    Wood LD; Canto MI; Jaffee EM; Simeone DM
    Gastroenterology; 2022 Aug; 163(2):386-402.e1. PubMed ID: 35398344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.